Fibromuscular Dysplasia Society of America Inc (EIN 010771966) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Tax Period

2022-01-01 to 2022-12-31

Fibromuscular Dysplasia Society of America Inc, founded in 2003, is a small nonprofit in the Medical Research sector that reported $142K in total revenue in fiscal year 2022. Revenue fell 30% from the prior year — a significant decline worth monitoring. Expenses of $163K exceeded revenue, resulting in a 14% operating deficit.

Mission

FMDSA is a public health charity working towards better diagnosis and treatment of Fibromuscular Displasia (FMD). We do this by building awareness of FMD, funding research activities, providing patient support, and educating patients and the healthcare community.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $142,236

Program Service Revenue $0

Investment Income $11

Other Revenue $0

TOTAL REVENUE $142,247

Expense Breakdown

Grants Paid $50,000

Salaries & Benefits $76,440

Fundraising Expenses $14,849

Program Expenses $135,639

Other Expenses $33,874

TOTAL EXPENSES $162,689

Year-over-Year Comparison

	2022	2021	Change
Revenue	$142,247	$202,620	-0.3%
Expenses	$162,689	$157,746	+0.0%
Net Income	$-20,442	$44,874	-1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Allison Gaines	Director at large	2.00	Director	$0	$0	$0
Cathlin Jamison	Director at large	16.00	Director	$0	$0	$0
Jazette Vicedor	Director-at-Large	1.50	Director	$0	$0	$0
Christi Eberhardt	Director at Large	0.50	Director	$0	$0	$0
Rochelle DesRochers	Director at Large	10.00	Director	$0	$0	$0
Bradley Daar	President	1.00	Officer Director	$0	$0	$0
Rosie Miklavcic	Treasurer	2.00	Officer Director	$0	$0	$0
Pamela Mace	Executive Director	60.00	Key Emp	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$142,247	$162,689	$175,125	$-20,442
2021	$202,620	$157,746	$199,366	$44,874
2020	$150,966	$154,404	$161,979	$-3,438
2019	$224,913	$173,027	$154,206	$51,886
2018	$184,053	$163,382	$104,964	$20,671

Fibromuscular Dysplasia Society of America Inc